Inpharmatica launches Admensa Interactive

Published: 17-Feb-2005

Inpharmatica has launched Admensa Interactive, its suite of predictive drug absorption, distribution, metabolism and excretion (ADME) models and compound prioritisation tools.


Inpharmatica has launched Admensa Interactive, its suite of predictive drug absorption, distribution, metabolism and excretion (ADME) models and compound prioritisation tools.

Inpharmatica already has a comprehensive suite of ADME products and services, which has attracted a strong client base since its launch in 2003, with the in-silico component of this suite now available for on site installation as Admensa Interactive.

Admensa Interactive combines an ability to predict accurately a wide range of compound properties for virtual or synthesised compounds and incorporate experimental data and evaluate it rigorously to aid effective decision-making. With an intuitive desk-top interface that can access extensive libraries of structures and compare individual project compounds, users can manipulate individual compound structures in real-time for individual ADME properties or overall compound quality. The suite additionally includes unique regio-selectivity technology to predict the points of metabolic attack on chemical compounds by major P450 metabolism enzymes.

Admensa Interactive is an integral component of PharmaCarta, Inpharmatica's gene-to-candidate tech-nology platform that integrates biology- and chemistry-based drug discovery activities.

You may also like